Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma

Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma

Abstract Background The relevance of estrogen receptor (ER) expression in pancreatic ductal adenocarcinoma (PDAC) is largely unknown. Clinical trials targeting ER with selective estrogen receptor modulators in pancreatic cancer did not show any benefit. Here, we analyze the impact of recently charac...

Full description

Bibliographic Details
Main Authors: Hendrik Seeliger, Ioannis Pozios, Gerald Assmann, Yue Zhao, Mario H. Müller, Thomas Knösel, Martin E. Kreis, Christiane J. Bruns
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Cancer
Subjects:
Pancreatic ductal adenocarcinoma
Pancreatic cancer
Estrogen receptor beta
Prognosis
Survival analysis
Tissue microarray
Online Access:http://link.springer.com/article/10.1186/s12885-018-4973-6

Internet

http://link.springer.com/article/10.1186/s12885-018-4973-6

Similar Items